ACTON, Mass. - In a strategic move to strengthen its financial leadership, the global leader in tubeless insulin pump technology, Insulet Corporation (NASDAQ: PODD), has announced the appointment of Ana Maria Chadwick as Executive Vice President, Chief Financial Officer (CFO), and Treasurer. Chadwick will assume her new role effective April 22, 2024, signaling an exciting new chapter for the company.
The selection of Chadwick as CFO comes after an extensive search process conducted by Insulet Corporation, which sought an individual who could contribute to maintaining and expanding the company’s success. With her extensive financial expertise and strategic insights, Chadwick is poised to play a pivotal role in driving the company’s growth trajectory.
With a proven track record in corporate finance, Chadwick brings a wealth of experience to her new position. Her appointment follows a string of impressive financial achievements by Insulet Corporation, including a remarkable return on average invested assets (ROI) of 10.29% in the fourth quarter of 2023 - a new high for the company. This achievement reflects the corporation’s commitment to financial excellence and serves as a testament to its sustained success.
Commenting on Chadwick’s appointment, Jim Hollingshead, President of Insulet Corporation, expressed his enthusiasm, stating, We are thrilled to welcome Ana to Insulet. Her proven leadership and financial acumen will be invaluable as we continue to push boundaries and enhance our market position in delivering innovative solutions to people with diabetes.
As the new CFO, Chadwick will be responsible for overseeing the company’s financial operations, providing strategic guidance to fuel growth, and ensuring financial stability. With Insulet Corporation poised for further expansion and advancements, Chadwick’s expertise will be vital in capitalizing on the opportunities that lie ahead.
Insulet Corporation’s pioneering Omnipod brand, recognized globally for its cutting-edge tubeless insulin pump technology, has revolutionized the lives of individuals with diabetes. The company’s commitment to continuously improving their products aligns with Chadwick’s expertise in financial management, making her appointment a promising step toward realizing Insulet Corporation’s vision.
In summary, the appointment of Ana Maria Chadwick as Insulet Corporation’s CFO marks a significant milestone in the company’s financial leadership. The decision reflects the organization’s commitment to sustained success and paves the way for continued growth and innovation under Chadwick’s stewardship.
Comments